Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Guardion Health Sciences, Inc is a drug manufacturers-specialty & generic business based in the US. Guardion Health Sciences shares (GHSI) are listed on the NASDAQ and all prices are listed in US Dollars. Guardion Health Sciences employs 21 staff and has a trailing 12-month revenue of around USD$1.9 million.
|Latest market close||USD$0.229|
|52-week range||USD$0.165 - USD$0.6175|
|50-day moving average||USD$0.2374|
|200-day moving average||USD$0.3024|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.385|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-08)||-68.80%|
|1 month (2020-12-16)||2.69%|
|3 months (2020-10-15)||11.71%|
|6 months (2020-07-15)||-46.99%|
|1 year (2020-01-15)||-33.58%|
|2 years (2019-01-12)||N/A|
|3 years (2018-01-12)||N/A|
|5 years (2016-01-12)||N/A|
|Revenue TTM||USD$1.9 million|
|Gross profit TTM||USD$561,622|
|Return on assets TTM||-47.92%|
|Return on equity TTM||-98.77%|
|Market capitalisation||USD$30.2 million|
TTM: trailing 12 months
There are currently 409,410 Guardion Health Sciences shares held short by investors – that's known as Guardion Health Sciences's "short interest". This figure is 57.7% down from 968,649 last month.
There are a few different ways that this level of interest in shorting Guardion Health Sciences shares can be evaluated.
Guardion Health Sciences's "short interest ratio" (SIR) is the quantity of Guardion Health Sciences shares currently shorted divided by the average quantity of Guardion Health Sciences shares traded daily (recently around 5.8 million). Guardion Health Sciences's SIR currently stands at 0.07. In other words for every 100,000 Guardion Health Sciences shares traded daily on the market, roughly 70 shares are currently held short.
However Guardion Health Sciences's short interest can also be evaluated against the total number of Guardion Health Sciences shares, or, against the total number of tradable Guardion Health Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Guardion Health Sciences's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Guardion Health Sciences shares in existence, roughly 0 shares are currently held short) or 0.0048% of the tradable shares (for every 100,000 tradable Guardion Health Sciences shares, roughly 5 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Guardion Health Sciences.
Find out more about how you can short Guardion Health Sciences stock.
We're not expecting Guardion Health Sciences to pay a dividend over the next 12 months.
Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Medical Devices. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. The Medical Devices segment offers VectorVision, which develops, manufactures, and sells equipment and supplies for standardized vision testing for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing; CSV-1000, an instrument for contrast sensitivity, glare sensitivity, low contrast acuity, and early treatment diabetic retinopathy; CSV-2000, a digital standardized contrast sensitivity testing device; and MapcatSF, a medical device that measures the macular pigment optical density. The company distributes its products through sales force, as well as through its guardionhealth.com Website. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.
Everything we know about the Vacasa IPO, plus information on how to buy in.
Everything we know about the William Penn Bancorp IPO, plus information on how to buy in.
Everything we know about the Landos Biopharma Inc IPO, plus information on how to buy in.
Everything we know about the First High-School Education Group Co Ltd IPO, plus information on how to buy in.
Everything we know about the Knowlton Development Corp IPO, plus information on how to buy in.
Steps to owning and managing SASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing SAIL, with 24-hour and historical pricing before you buy.
Steps to owning and managing SAF, with 24-hour and historical pricing before you buy.
Steps to owning and managing RDHL, with 24-hour and historical pricing before you buy.
Steps to owning and managing SBFG, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.